Edan Diagnostics

Founded in 1995 and headquartered in San Diego, Edan Diagnostics has grown into a significant international player in the medical device and diagnostics sector, publicly listed on the Shenzhen Stock Exchange (300206.SZ). The company's mission is to improve global healthcare through a broad portfolio of high-quality products, supported by a consistent R&D investment exceeding 20% of revenue. Its strategy centers on innovation across multiple modalities—including ultrasound, patient monitoring, and IVD—and is increasingly focused on digital integration through its EDAN Allink platform and expansion into adjacent markets like animal health.

An integrated platform combining hardware engineering, advanced software, and digital connectivity (EDAN Allink IoT) across multiple diagnostic modalities including ultrasound, patient monitoring, and in-vitro diagnostics.

Competes with multinational giants (GE, Philips, Siemens) in imaging/monitoring and diagnostics leaders (Roche, Abbott) in IVD, as well as regional value players. Edan's advantages include a strong value proposition, agile R&D, a broad integrated portfolio, and an extensive global distribution network.